Iranian Society of Gynecology Oncology

Document Type : Case Report Article

Authors

1 Department of Obstetrics and Gynecology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

2 Department of Pathology, School of Medicine, Isfahan University of Medical Sciences, Isfahan, Iran

3 Vali-E-Asr Reproductive Health Research Center, Family Health Research Institute, Tehran University of Medical Sciences, Tehran, Iran

Abstract

Invasive angiomyxoma as a mesenchymal tumor with a high recurrence rate has been reported mainly in reproductive age according to its association with the estrogenic level of plasma. Above that, it seems there is a need for further treatment despite complete resection of the tumor, to eliminate the hormonal state. In the present study, we sought to introduce a rare case of invasive angiomyxoma in a post-menopausal but high-risk woman, discuss the relativity of risk factors in all hormonal-dependent gynecological malignancy, and intend to seek help from colleagues' opinions and experiences about treatment. It is clearly of great importance to emphasize the role of individualized medicine in such a rare case, in conclusion, there is not any debate on the role of surgical resection but the necessity of changing in lifestyle or adjuvant systemic or local therapy, and the needed duration is doubtful.

Keywords

Main Subjects

1. Zizi-Sermpetzoglou A, Myoteri D, Koulia K, Kontostolis V, Moschouris H, Dellaportas D. Aggressive Angiomyxoma of the Vulva: A Bizarre Perineal Lesion. Case Rep Oncol Med. 2015;2015:292304. [DOI:10.1155/2015/292304] [PMID] [PMCID]
2. Sozutek A, Irkorucu O, Reyhan E, Yener K, Besen AA, Erdogan KE, et al. A Giant Aggressive Angiomyxoma of the Pelvis Misdiagnosed as Incarcerated Femoral Hernia: A Case Report and Review of the Literature. Case Rep Surg. 2016;2016:9256749. [DOI:10.1155/2016/9256749] [PMID] [PMCID]
3. Lee K-A, Seo J-W, Yoon N-R, Lee J-W, Kim B-G, Bae D-S. Aggressive angiomyxoma of the vulva: A case report. Obstet Gynecol Sci. 2014;57(2):164-7. [DOI:10.5468/ogs.2014.57.2.164] [PMID] [PMCID]
4. Fine BA, Munoz AK, Litz CE, Gershenson DM. Primary Medical Management of Recurrent Aggressive Angiomyxoma of the Vulva with a Gonadotropin-Releasing Hormone Agonist. Gynecol Oncol. 2001;81(1):120-2. [DOI:10.1006/gyno.2000.6119] [PMID]
5. Sun Y, Zhu L, Chang X, Chen J, Lang J. Clinicopathological features and treatment analysis of rare aggressive angiomyxoma of the female pelvis and perineum-a retrospective study. Pathol Oncol Res. 2017;23:131-7. [DOI:10.1007/s12253-016-0109-y] [PMID]
6. Danesh A, Sanei MH. Aggressive angiomyxoma of the vulva: dramatic response to gonadotropin-releasing hormone agonist therapy. J Res Med Sci. 2007;12(4):217.
7. Kaira V, Gupta AK, Kaur A. Aggressive Angiomyxoma: An Uncommon Entity with Literature Review. Clin Cancer Investig J. 2017;6(4):197. [DOI:10.4103/ccij.ccij_39_17]